Page last updated: 2024-08-18

dimethyldioctadecylammonium and Cystic Fibrosis

dimethyldioctadecylammonium has been researched along with Cystic Fibrosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ackerley, C; Cassady, R; Chonn, A; Griesenbach, U; Hannam, V; O'Brodovich, H; Olek, K; Post, M; Tanswell, AK1
Belcastro, R; Downey, G; Hannam, V; Hu, J; Koehler, DR; Post, M; Steer, B; Tanswell, AK; Wen, Y1

Other Studies

2 other study(ies) available for dimethyldioctadecylammonium and Cystic Fibrosis

ArticleYear
Comparison between intratracheal and intravenous administration of liposome-DNA complexes for cystic fibrosis lung gene therapy.
    Gene therapy, 1998, Volume: 5, Issue:2

    Topics: Analysis of Variance; Animals; Autoradiography; Bronchi; Cations; Chloramphenicol O-Acetyltransferase; Cystic Fibrosis; Epithelial Cells; Gene Expression; Gene Transfer Techniques; Genetic Therapy; Immunohistochemistry; Injections, Intravenous; Liposomes; Mice; Mice, Inbred Strains; Phosphatidylethanolamines; Pulmonary Alveoli; Quaternary Ammonium Compounds; Trachea

1998
Targeting transgene expression for cystic fibrosis gene therapy.
    Molecular therapy : the journal of the American Society of Gene Therapy, 2001, Volume: 4, Issue:1

    Topics: Animals; Cystic Fibrosis; Gene Expression; Gene Transfer Techniques; Genetic Therapy; Genetic Vectors; Glycerophospholipids; Humans; Injections, Intravenous; Keratins; Lac Operon; Liposomes; Mice; Mice, Inbred Strains; Organ Specificity; Phosphatidylethanolamines; Quaternary Ammonium Compounds; Surface-Active Agents; Tissue Distribution; Transgenes

2001